TWiV 691: SciArt with Laura Splan
SciArtist Laura Splan joins TWiV to reveal her transdisciplinary work that intersects science, technology, design and culture, then we discuss an inverse correlation between mumps virus antibodies induced by MMR vaccine and COVID-19 severity, and whether ivermectin is indicated for treatment of COVID-19. Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Brianne Barker Guest: Laura Splan Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Laura Splan website BSL-3 Assistant Manager position MMR titers in recovered COVID-19 patients (mBio) Ivermectin and SAR...
Source: This Week in Virology - MP3 Edition - December 10, 2020 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Corona virus second wave - the vaccine's here, but the pandemic isn't over
As the first people outside of a trial have started receiving Pfizer's sars-cov-2 vaccine, including Matt, but that's not the end of the story for the pandemic, there are still logistics of rollout, plus treating those who have already contracted the disease.
In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.
They discuss why it's impossible to get the vaccine into care homes, because of the need for very low temperature storage, why the survival rate in ICU has gone down, and how messaging on the ...
Source: The BMJ Podcast - December 8, 2020 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Coronavirus second wave - the vaccine's here, but the pandemic isn't over
As the first people outside of a trial have started receiving Pfizer's sars-cov-2 vaccine, including Matt, but that's not the end of the story for the pandemic, there are still logistics of rollout, plus treating those who have already contracted the disease.
In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.
They discuss why it's impossible to get the vaccine into care homes, because of the need for very low temperature storage, why the survival rate in ICU has gone down, and how messaging on the ...
Source: The BMJ Podcast - December 8, 2020 Category: General Medicine Authors: BMJ talk medicine Source Type: podcasts
Coronavirus second wave - the vaccine ’s here, but the pandemic isn’t over
As the first people outside of a trial have started receiving Pfizer's sars-cov-2 vaccine, including Matt, but that's not the end of the story for the pandemic, there are still logistics of rollout, plus treating those who have already contracted the disease.
In this podcast, Fiona Godlee, editor in chief of The BMJ, talks to Matt Morgan, a consultant in a intensive care medicine in Cardiff, and Helen Salisbury, GP in Oxfordshire.
They discuss why it's impossible to get the vaccine into care homes, because of the need for very low temperature storage, why the survival rate in ICU has gone down, and how messaging on the n...
Source: The BMJ Podcast - December 8, 2020 Category: General Medicine Authors: BMJ Group Source Type: podcasts
TWiV 689: COVID-19 clinical update #39 with Dr. Daniel Griffin
Daniel Griffin provides his weekly clinical report on COVID-19, including analysis of vitamin D levels in patients, information on Moderna and Pfizer vaccines, distribution plans suggested by ACIP, and more. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Vitamin D levels in COVID-19 patients (Nature) ACIP recommendations for distribution of COVID-19 vaccine (MMWR) Updated CDC guidance on when to quarantine (CDC) Letters read on TWiV 689 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your virolog...
Source: This Week in Virology - MP3 Edition - December 5, 2020 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
Coronavirus Vaccine Update With Paul Offit
With the Pfizer and Moderna coronavirus vaccines reportedly under review at the US FDA for Emergency Use Authorization (EUA), Paul A. Offit, MD, of the Children's Hospital of Philadelphia, returns to JAMA's Q&A series to provide an update on what to expect, prospects for vaccine rollout and distribution in the coming months, and ongoing safety surveillance. Recorded December 2, 2020. Related Article: Developing a SARS-CoV-2 Vaccine at Warp Speed (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 4, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
TWiV 688: We put COVID-19 papers through a sieve
December 2, 2020 On this episode, UK grants EUA for Pfizer vaccine, advice for CDC on who to immunize first, news from Das Coronavirus, SARS-CoV-2 protease regulates innate responses, and viral mRNAs are not an indication of viral replication. Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Brianne Barker Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode UK grants EUA for Pfizer vaccine (NY Times) ACIP advice on who to vaccinate first (NY Times) Das coronavirus update SARS-CoV-2 protease regulates innate response (Nature) Viral mRNAs do not indicate ...
Source: This Week in Virology - MP3 Edition - December 3, 2020 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
TWiV 683: Two COVID-19 mRNA vaccines
On this episode of TWiV, mRNA vaccines from Moderna and Pfizer show over 90% efficacy, prothrombotic auto-antibodies in serum of COVID-19 patients, and the whereabouts of SARS-CoV-2 in the human body. Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Brianne Barker Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Efficacy of Moderna and Pfizer mRNA vaccines Longer shelf life of Moderna vaccine (Moderna) Prothrombotic antibodies in COVID-19 serum (Sci Trans Med) Where is SARS-CoV-2 in the human body? (PLoS Path) Letters read on TWiV 683 Timestamps by Jol...
Source: This Week in Virology - MP3 Edition - November 19, 2020 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
TWiV 681: Crowley, coats, and cross-reactive antibodies
Daniel Griffin provides a clinical report on COVID-19, Kathleen Crowley explains the role of Environmental Health & Safety departments, update on SARS-CoV-2 transmission in farmed mink, and the presence of pre-existing antibodies to SARS-CoV-2 in unexposed individuals. Hosts: Vincent Racaniello, Dickson Despommier, Alan Dove, Rich Condit, and Brianne Barker Guests: Daniel Griffin and Kathleen A. Crowley Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Pfizer vaccine efficacy (Pfizer) Pfizer vaccine (Stat) Distribution of Pfizer vaccine (NY Times) LSTMH vaccine tr...
Source: This Week in Virology - MP3 Edition - November 15, 2020 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
TWiV 644: Don't let perfect be the enemy of good
In this mid-week edition, identifying flawed research before it becomes dangerous, Michigan governor tells America to mask-up, Pfizer mRNA vaccine gets $1.95 billion from Warp Speed, preliminary phase I/II results of the ChAdOx1 SARS-CoV-2 vaccine, answers to listener questions. Hosts: Vincent Racaniello, Rich Condit, Kathy Spindler, and Brianne Barker Click arrow to play Download TWiV 644 (69 MB .mp3, 115 min) Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode US COVID-19 cases (NY Times) Identify flawed research before it is dangerous (NY Times) Mask up, America...
Source: This Week in Virology - MP3 Edition - July 23, 2020 Category: Virology Authors: Vincent Racaniello Source Type: podcasts
What Does Pfizer Backing Out of Alzheimer Research Mean to the Field?
Despite the abandonment of research by some pharmaceutical companies, Dr Isaacson is very hopeful about the future of Alzheimer disease treatment and prevention. (Source: Medscape Neurology Podcast)
Source: Medscape Neurology Podcast - February 27, 2018 Category: Neurology Authors: Medscape Source Type: podcasts
Besponsa (Inotuzumab Ozogamicin) Trial Overview & amp; Conclusions - Hagop M. Kantarjian, MD
Hagop M. Kantarjian, MD of MD Anderson Cancer Center's Department of Leukemia gives the trial overview and conclusions of Pfizer's newly approved FDA CD22-directed antibody-drug conjugate Besponsa (In...
Author: Cancer-News
Added: 08/29/2017 (Source: Oncology Tube)
Source: Oncology Tube - August 29, 2017 Category: Cancer & Oncology Source Type: podcasts
Feburary 16 2016 Issue
1) Neurology® Neuroimmunology & Neuroinflammation: Vasculitis neuropathy following exposure to minocycline 2) e-Pearl topic: Primary progressive aphasia3) Topic of the month: Neurology Today story about a wearable EEG device This podcast for the Neurology Journal begins and closes with Dr. Robert Gross, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ted Burns interviews Dr. Chafic Karam about his Neurology: Neuroimmunology & Neuroinflammation paper on vasculitis neuropathy following exposure to minocycline. Dr. Ilena George is reading our e-Pearl of ...
Source: Neurology Podcast - February 15, 2016 Category: Neurology Authors: American Academy of Neurology Source Type: podcasts
